ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00652054
Recruitment Status : Completed
First Posted : April 3, 2008
Last Update Posted : March 18, 2011
Sponsor:
Collaborator:
Quintiles, Inc.
Information provided by:
Taiho Oncology, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2007
  Actual Study Completion Date : October 2007